Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
Microdosing GLP-1s for cosmetic weight loss: Patients are asking me about it, TV and online ads are promoting it, friends are speculating about who’s doing it. But as someone who prescribes only legitimate GLP-1 therapies to people with obesity and weight-related metabolic diseases, I need to say this: Microdosing GLP-1s is not a thing. There Read More
Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concernsWeight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns
Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain Read More
Obesity may influence how breast cancer spreadsObesity may influence how breast cancer spreads
Obesity may change how early-stage breast cancer becomes invasive, according to a study by University of Oklahoma researchers published in The American Journal of Pathology.
GLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI BleedingGLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI Bleeding
(MedPage Today) — A real-world study of chronic pancreatitis found GLP-1 agonists to be associated with less pain medication use and lower risks for pancreatic interventions, including major surgery. (Gastro Hep Advances) The FDA expanded the… (MedPage Today) — A real-world study of chronic pancreatitis found GLP-1 agonists to be associated with less pain Read More
Health Roundup: GLP-1s, ‘Sweet Spot’ for Sleep, MoreHealth Roundup: GLP-1s, ‘Sweet Spot’ for Sleep, More
Dr. John Torres, NBC News medical contributor joins TODAY with a roundup of the biggest health stories people are talking about from GLP-1s, to sleep health. He breaks down new studies that show GLP-1s may have even more anti-inflammatory benefits other than just weight loss and explains how to find your “sweet spot” in sleep. Read More
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlashCVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash
CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said. CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly Read More
Clinician Perspectives on Breast Cancer–Related Lymphedema Prospective ScreeningClinician Perspectives on Breast Cancer–Related Lymphedema Prospective Screening
This qualitative study explores clinicians’ perspectives on the barriers to and facilitators of prospective screening for lymphedema among breast cancer survivors.
Weight-loss program helps women battling breast cancerWeight-loss program helps women battling breast cancer
Women battling breast cancer can benefit from a phone-based weight loss program, according to a new study. The Breast Cancer Weight Loss (BWEL) program helped women drop excess pounds, improve their physical function and have a better quality of life overall, researchers are scheduled to report at the annual meeting of the American Society of Clinical Oncology (ASCO).
If You’re On Or Have Been On GLP-1 Medication, I Want To Know Your “Why”If You’re On Or Have Been On GLP-1 Medication, I Want To Know Your “Why”
Influencers have had their say and time on the soapbox — let’s hear from “real” people, please. View Entire Post › Influencers have had their say and time on the soapbox — let’s hear from “real” people, please. View Entire Post ›
Tirzepatide superior to intensified conventional care for early type 2 diabetesTirzepatide superior to intensified conventional care for early type 2 diabetes
Tirzepatide is superior to intensified conventional care (ICC) for adults with early type 2 diabetes (T2D) uncontrolled with metformin, according to a study published online May 26 in the Annals of Internal Medicine. Tirzepatide is superior to intensified conventional care (ICC) for adults with early type 2 diabetes (T2D) uncontrolled with metformin, according to a Read More